[Federal Register Volume 84, Number 236 (Monday, December 9, 2019)]
[Notices]
[Pages 67276-67277]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-26441]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Tick-Borne Disease Working Group

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As required by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the Tick-Borne Disease Working Group (TBDWG) will hold a meeting. 
The meeting will be open to the public. For this meeting, the TBDWG 
will (1) hear presentations from eight subcommittees on findings and 
potential actions from reports prepared for the TBDWG to consider and 
(2) further discuss plans for developing the next report to the HHS 
Secretary and Congress on federal tick-borne activities and research, 
taking into consideration the 2018 report. The 2020 report will address 
ongoing tick-borne disease research, including research related to 
causes, prevention, treatment, surveillance, diagnosis, diagnostics, 
duration of illness, and intervention for individuals with tick-borne 
diseases; advances made pursuant to such research; federal activities 
related to tick-borne diseases; and gaps in tick-borne disease 
research.

DATES: The meeting will be held on January 28-29, 2020, from 9:00 a.m. 
to 4:30 p.m. ET (times are tentative and subject to change). The 
confirmed times and agenda items for the meeting will be posted on the 
website for the TBDWG at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2020-1-28/index.html when this information 
becomes available.

ADDRESSES: The meeting will be held at Hyatt Place Washington DC/US 
Capitol, 33 New York Avenue NE, Washington, DC 20002. Members of the 
public may also attend the meeting via webcast. Instructions for 
attending via webcast will be posted one week prior to the meeting at 
https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2020-1-28/index.html.

FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal 
Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS 
Policy, Office of the Assistant Secretary for Health, Department of 
Health and Human Services, Mary E Switzer Building, 330 C Street SW, 
Suite L600, Washington, DC 20024. Email: [email protected]; 
Phone: 202-795-7608.

SUPPLEMENTARY INFORMATION: In-person attendance at the meeting is 
limited to space available; therefore, preregistration for public 
members is advisable and can be accomplished by registering at https://www.eventbrite.com/e/tick-borne-disease-working-group-meeting-january-28-29-2020-meeting-11-tickets-81603750013. On the day of the meeting, 
seating will be provided first to persons who have preregistered. 
People who have not preregistered will be accommodated on a first come, 
first served basis if additional seats are still available 10 minutes 
before the meeting starts. Non-U.S. citizens who plan to attend in 
person are required to provide additional information and must notify 
the Working Group support staff via email at [email protected] 
before December 28, 2019.
    The public will have an opportunity to present their views orally 
to the TBDWG during the meeting's public comment session or by 
submitting a written public comment. Comments should be pertinent to 
the meeting discussion. Persons who wish to provide verbal or written 
public comment should review instructions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2020-1-28/index.html and 
respond by midnight Tuesday, January 17, 2020, ET. Verbal comments will 
be limited to three minutes each to accommodate as many speakers as 
possible during the two 30 minute sessions. Written public comments 
will be accessible to the TBDWG members and made public on the TBDWG 
web page prior to the meeting.
    Background and Authority: The Tick-Borne Disease Working Group was 
established on August 10, 2017, in accordance with Section 2062 of the 
21st Century Cures Act, and the Federal Advisory Committee Act, 5 
U.S.C. App., as amended, to provide expertise and review federal 
efforts related to all tick-borne diseases, to help ensure interagency 
coordination and minimize overlap, and to examine research priorities. 
The TBDWG is required to submit a report to the HHS Secretary and 
Congress on their findings and any recommendations for the federal 
response to tick-borne disease every two years.


[[Page 67277]]


    Dated: December 3, 2019.
James Berger,
Designated Federal Officer, Tick-Borne Disease Working Group, Office of 
Infectious Disease and HIV/AIDS Policy.
[FR Doc. 2019-26441 Filed 12-6-19; 8:45 am]
 BILLING CODE 4150-28-P